Medigus Ltd.
Symbool: MDGS
NASDAQ
2.745
USDMarktprijs vandaag
-0.2062
Koers/Winst Verhouding
-0.0022
Koers/Winst Groei Verhouding
4.67M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Medigus Ltd. (MDGS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 79.33 | 25.1 | 27.3 | 22.4 | ||||||||||
balance-sheet.row.short-term-investments | 8.11 | 5 | 3.3 | 0 | ||||||||||
balance-sheet.row.net-receivables | 94.87 | 25.2 | 1.7 | 0.3 | ||||||||||
balance-sheet.row.inventory | 8.67 | 1.8 | 1.2 | 0.2 | ||||||||||
balance-sheet.row.other-current-assets | 21.11 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-current-assets | 197.6 | 52.3 | 31.7 | 24 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 3.82 | 1 | 0.1 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 36.23 | 9.1 | 0.9 | 0.3 | ||||||||||
balance-sheet.row.intangible-assets | 87.71 | 21.8 | 7.4 | 0.5 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 123.94 | 30.9 | 8.3 | 0.5 | ||||||||||
balance-sheet.row.long-term-investments | 39.56 | 13.1 | 18.8 | 6.2 | ||||||||||
balance-sheet.row.tax-assets | 0.85 | 0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -83.66 | 0 | 0.8 | 1.2 | ||||||||||
balance-sheet.row.total-non-current-assets | 168.18 | 45.4 | 28.1 | 8.3 | ||||||||||
balance-sheet.row.other-assets | 0.85 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 366.64 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.account-payables | 78.02 | 20.4 | 0.7 | 0.1 | ||||||||||
balance-sheet.row.short-term-debt | 14.76 | 6.7 | 0.9 | 0.1 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 12.98 | 3.4 | 0.7 | 0 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 2.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.56 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 49.74 | 10.4 | 4.9 | 3.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 16.68 | 5.3 | 1.7 | 2.6 | ||||||||||
balance-sheet.row.other-liabilities | 4.67 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 1.25 | 0.6 | 0 | 0.1 | ||||||||||
balance-sheet.row.total-liab | 168.36 | 43 | 8.3 | 6.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 93 | ||||||||||
balance-sheet.row.retained-earnings | -358.74 | -85.6 | -74.2 | -81 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 26.97 | 13.2 | 12.6 | 10.7 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 473.58 | 111.5 | 110.8 | 0.2 | ||||||||||
balance-sheet.row.total-stockholders-equity | 141.81 | 39.1 | 49.2 | 23 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 183.32 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.minority-interest | 56.46 | 15.5 | 2.2 | 3.2 | ||||||||||
balance-sheet.row.total-equity | 198.27 | 54.7 | 51.4 | 26.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 183.32 | - | - | - | ||||||||||
Total Investments | 47.67 | 18.1 | 22.2 | 6.2 | ||||||||||
balance-sheet.row.total-debt | 21.73 | 10.1 | 1.6 | 0.1 | ||||||||||
balance-sheet.row.net-debt | -43.12 | -9.9 | -22.4 | -22.3 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.79 | -10.1 | 4.2 | -6.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 5.1 | 3.2 | 0.3 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | -5.51 | 0.4 | -12.8 | -1.1 | |||||||||||
cash-flows.row.stock-based-compensation | 0.63 | 0.8 | 2.4 | 1.4 | |||||||||||
cash-flows.row.change-in-working-capital | -2.08 | -1.1 | 0.1 | -0.3 | |||||||||||
cash-flows.row.account-receivables | -3.62 | -7.8 | -0.2 | -0.1 | |||||||||||
cash-flows.row.inventory | -1.09 | -0.6 | -0.6 | -0.5 | |||||||||||
cash-flows.row.account-payables | 3.64 | 5.8 | 1 | 0.1 | |||||||||||
cash-flows.row.other-working-capital | -1.01 | 1.4 | -0.1 | 0.2 | |||||||||||
cash-flows.row.other-non-cash-items | 14.17 | 1.2 | 0.6 | 0.5 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.5 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.acquisitions-net | -2.92 | -2.4 | -7.7 | -1.3 | |||||||||||
cash-flows.row.purchases-of-investments | -2.86 | -6.6 | -0.2 | -1.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 1.24 | 0.5 | 1.9 | 3.1 | |||||||||||
cash-flows.row.other-investing-activites | -5.45 | 4.1 | -6.2 | -1.3 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.79 | -4.5 | -12.4 | -1.6 | |||||||||||
cash-flows.row.debt-repayment | -3.32 | -4.7 | -1.5 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 13.25 | 12.6 | 18.7 | 23 | |||||||||||
cash-flows.row.common-stock-repurchased | -2.38 | 0 | 0 | -22.9 | |||||||||||
cash-flows.row.dividends-paid | -7.11 | -4.2 | 0 | -0.1 | |||||||||||
cash-flows.row.other-financing-activites | 1.72 | 1.8 | 1.9 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.18 | 5.4 | 19.1 | 22.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.88 | 0.8 | 0.2 | 0.1 | |||||||||||
cash-flows.row.net-change-in-cash | -14.71 | -4 | 1.7 | 15.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 50.04 | 20.1 | 24 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 64.75 | 24 | 22.4 | 7 | |||||||||||
cash-flows.row.operating-cash-flow | -9.5 | -5.7 | -5.3 | -6.1 | |||||||||||
cash-flows.row.capital-expenditure | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.free-cash-flow | -11.29 | -5.7 | -5.4 | -6.5 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 166.86 | 91.9 | 10.1 | 0.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 141.96 | 77.4 | 5.3 | 1 | |||||||||||
income-statement-row.row.gross-profit | 24.9 | 14.5 | 4.8 | -0.5 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 8.23 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 16.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 40.69 | 23 | 13 | 7 | |||||||||||
income-statement-row.row.cost-and-expenses | 182.65 | 100.4 | 18.3 | 8 | |||||||||||
income-statement-row.row.interest-income | 2.49 | 2.3 | 0.3 | 0.2 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 5.1 | 1.8 | -14 | -0.5 | |||||||||||
income-statement-row.row.ebitda-caps | -9.36 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -14.45 | -13.8 | -8.2 | -7.4 | |||||||||||
income-statement-row.row.income-before-tax | -20.2 | -10.1 | 4.2 | -6.8 | |||||||||||
income-statement-row.row.income-tax-expense | 0.42 | 0.1 | 0.1 | 0 | |||||||||||
income-statement-row.row.net-income | -21.79 | -10.2 | 4 | -6.8 |
Vaak gestelde vragen
Wat is Medigus Ltd. (MDGS) totale activa?
Medigus Ltd. (MDGS) totale activa is 97651000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 80077500.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.150.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.135.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.086.
Wat is Medigus Ltd. (MDGS) nettowinst (netto-inkomen)?
De nettowinst is -10208000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 10135000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 23033000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 12359000.000.